Listed

Emergent BioSolutions Inc.: Form 10-K for the period ended Dec 31, 2015

Filed with the SEC on Feb 29, 2016 and accepted by EDGAR at Feb 29, 2016, 14:31 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-10-01 to 2015-12-31$168.1mus-gaap:SalesRevenueNet
Revenue12 months2015-01-01 to 2015-12-31$522.8mus-gaap:Revenues
Cost of revenue12 months2015-01-01 to 2015-12-31$124.3mus-gaap:CostOfGoodsSold
Research and development12 months2015-01-01 to 2015-12-31$154.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2015-01-01 to 2015-12-31$148.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2015-10-01 to 2015-12-31$49.9mus-gaap:OperatingIncomeLoss
Operating income12 months2015-01-01 to 2015-12-31$96.0mus-gaap:OperatingIncomeLoss
Interest expense12 months2015-01-01 to 2015-12-31$6.5mus-gaap:InterestExpense
Income tax12 months2015-01-01 to 2015-12-31$26.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-10-01 to 2015-12-31$33.3mus-gaap:NetIncomeLoss
Net income12 months2015-01-01 to 2015-12-31$62.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-10-01 to 2015-12-31$0.71us-gaap:EarningsPerShareDiluted
Diluted EPS12 months2015-01-01 to 2015-12-31$1.41us-gaap:EarningsPerShareDiluted
Basic EPS3 months2015-10-01 to 2015-12-31$0.85us-gaap:EarningsPerShareBasic
Basic EPS12 months2015-01-01 to 2015-12-31$1.63us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2015-01-01 to 2015-12-3147,255,842 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Capital expenditure12 months2015-01-01 to 2015-12-31$44.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases12 months2015-01-01 to 2015-12-31$100.0kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2015-12-31$312.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-12-31$538.6mus-gaap:AssetsCurrent
Total assetsAt period end2015-12-31$1.04bnus-gaap:Assets
Current liabilitiesAt period end2015-12-31$99.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-12-31$383.6mus-gaap:Liabilities
Long-term debtAt period end2015-12-31$253.0mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2015-12-31$660.0mus-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Source: SEC EDGAR, the filing index for accession 0001367644-16-000059. Last ingested by Listed: Nov 4, 2026, 16:51 ET. Listed shows no prices and gives no investment advice.